Hongxing Pan
National Health Commission Key Laboratory Of Enteric Pathogenic Microbiology
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies.
Journal: Infectious diseases and therapy
Published: May 16, 2026
Protective outcomes of high-affinity monoclonal antibodies against drug-resistant plague strains.
Journal: Frontiers in immunology
Published: March 21, 2026
Post-Marketing Active Surveillance of Adverse Events Following Quadrivalent Subunit Influenza Vaccine in Healthy Participants Aged ≥ 3 Years in China.
Journal: Infectious diseases and therapy
Published: March 12, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
Journal: The Pediatric infectious disease journal
Published: February 18, 2026
Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccines.
Journal: Expert review of vaccines
Published: February 04, 2026
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial.
Journal: Vaccines
Published: September 26, 2025
Immunogenicity and safety of an Escherichia coli-produced 9-valent human papillomavirus vaccine (types 6/11/16/18/31/33/45/52/58) in healthy Chinese women aged 20-45 years: a single-center, randomized, observer-blinded, positive controlled phase 2 clinical trial.
Journal: Frontiers in immunology
Published: September 16, 2025
Active Surveillance on Safety and Compliance of Freeze-dried Human Rabies Vaccine (Vero Cell) - Jiangsu Province, China, 2023-2024.
Journal: China CDC weekly
Published: May 29, 2025
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 27, 2025
The Factors Influencing the Incidence, Persistence, and Severity of Symptoms After SARS-CoV-2 Infection in Chinese Adults: A Case-Control Study.
Journal: Tropical medicine and infectious disease
Published: May 01, 2025
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China.
Journal: Expert review of vaccines
Published: February 07, 2025
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Journal: Human vaccines & immunotherapeutics
Published: January 27, 2025
Last Updated: 09/26/2026